Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 08, 2022 / 02:50PM GMT
Georgi Nenov Yordanov
Cowen and Company, LLC, Research Division - Specialty Pharma Associate
All right. Welcome, everyone. I'm really excited to have Novavax Management, specifically John Trizzino, Chief Operating Officer (sic) [Chief Commercial Officer] and Chief Business Officer; as well as Filip Dubovsky, who is the Chief Medical Officer of Novavax.
Questions & Answers
Georgi Nenov Yordanov
Cowen and Company, LLC, Research Division - Specialty Pharma Associate
So obviously, you guys just had your quarterly call last week, issued your 2022 guidance of $4 billion to $5 billion. So maybe we can just get right into it and then maybe you can just walk us through the different components that make up this guidance, and then we can take it from there.
John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer
Yes. Sure. Georgi, first of all, thanks for having us. I think it was an exciting earnings call. It's chock-full of -- a lot of information about where the company is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot